{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:28:33Z","timestamp":1774056513541,"version":"3.50.1"},"reference-count":59,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2518,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.00996.x","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T16:05:37Z","timestamp":1150128337000},"page":"835-846","source":"Crossref","is-referenced-by-count":12,"title":["Neurohormones and heart failure: the importance of aldosterone"],"prefix":"10.1155","volume":"60","author":[{"given":"K.","family":"ODEDRA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"FERRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB1|cit1","unstructured":"Department of Health, UK. The National Service Framework for Coronary Heart Disease: Winning the war on heart disease. Progress report 2004. http:\/\/www.dh.gov.uk"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.0305-1870.2004.04073.x","article-title":"Cardioprotective functions of atrial natriuretic peptide and B-type natriuretic peptide: a brief review","volume":"31","author":"Woods","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1527-5299.2005.03794.x","article-title":"A review of the renal and neurohormonal effects of B-type natriuretic peptide","volume":"11","author":"Burger","year":"2005","journal-title":"Congest Heart Fail"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(95)90141-8","article-title":"\u2019Til death do us part: a case of failed affection","volume":"30","author":"Villarreal","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2003.10.004","article-title":"From CONSENSUS to CHARM - how do ACEI and ARB produce clinical benefits in CHF","volume":"94","author":"Tan","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.0000144474.65922.AA","article-title":"Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"110","author":"Solomon","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomised trial of the angiotensin receptor blocker Valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left ventricular systolic function taking angiotensin converting inhibitors: the CHARM added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.CIR.96.7.2197","article-title":"Prognostic value of bisoprolol-induced haemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS)","volume":"96","author":"Lechat","year":"1997","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02627961","article-title":"Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial","volume":"10","author":"Wiklund","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB13|cit13","first-page":"1","article-title":"The effect of adrenal extract on mineral metabolism","volume":"1","author":"Tait","year":"1952","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone- and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/01.CIR.82.5.1730","article-title":"Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality","volume":"82","author":"Swedberg","year":"1990","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0002-9149(00)00729-3","article-title":"Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ishcaemic cardiomyopathy","volume":"85","author":"Ramires","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0008-6363(97)00072-2","article-title":"Monitoring fibrillar collagen turnover in hypertensive heart disease","volume":"35","author":"Diez","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00050990","article-title":"Pathologic consequences of increased angiotensin II activity","volume":"10","author":"Ferrario","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1071-9164(96)80009-1","article-title":"Aldosterone escape during angiotensin converting enzyme inhibition therapy in chronic heart failure","volume":"2","author":"Struthers","year":"1996","journal-title":"J Card Fail"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11906-000-0017-z","article-title":"Aldosterone and vascular damage","volume":"2","author":"Duprez","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119249","article-title":"Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion","volume":"99","author":"Okubo","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and haemodynamics in heart failure","volume":"341","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB25|cit25","first-page":"721","article-title":"Pathogenesis of ascites formation: mechanism of impaired aldosterone escape in cirrhosis","volume":"3","author":"Schrier","year":"1991","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000168356","article-title":"Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention","volume":"11","author":"Hensen","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmcc.1996.0072","article-title":"High affinity NAD+-dependent 11\u03b2-hydroxysteroid dehydrogenase in the human heart","volume":"28","author":"Slight","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB28|cit28","first-page":"234","article-title":"Aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) gene expression in the normal and failing rat heart","volume":"5","author":"Millar","year":"2003","journal-title":"Endocr Abstr"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/01.HYP.36.4.495","article-title":"Cardiac aldosterone production in genetically hypertensive rats","volume":"36","author":"Takeda","year":"2000","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/01.CIR.103.1.72","article-title":"Aldosterone production is activated in failing ventricle in humans","volume":"103","author":"Mizuno","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/jcem.87.8.8731","article-title":"Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real time polymerase chain reaction","volume":"87","author":"Yoshimura","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(01)01539-X","article-title":"Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction","volume":"38","author":"Hayashi","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-L-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB37|cit37","first-page":"H1802","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","volume":"37","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2362.2004.01400.x","article-title":"Aldosterone antagonism in heart failure: improvement of cardiac remodeling, endothelial dysfunction and platelet activation","volume":"34","author":"Bauersachs","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","article-title":"Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s000590050024","article-title":"Aldosterone and myocardial fibrosis in heart failure","volume":"25","author":"Brilla","year":"2000","journal-title":"Herz"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0008-6363(97)00097-7","article-title":"Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion","volume":"35","author":"Sun","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone receptor antagonist in myocardial infarction","volume":"281","author":"Delyani","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/cs1020381","article-title":"Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart","volume":"102","author":"Satoh","year":"2002","journal-title":"Clin Sci"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/hy1101.099484","article-title":"Treatment of congestive heart failure. Interfering the aldosterone-cardiac extracellular matrix relationship","volume":"38","author":"Zannad","year":"2001","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2362.2004.01403.x","article-title":"Aldosterone: from integrative physiology to cellular biology and back","volume":"34","author":"Ertl","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11906-000-0017-z","article-title":"Aldosterone and vascular damage","volume":"2","author":"Duprez","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-7061(01)02291-9","article-title":"Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1","volume":"15","author":"Park","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/ndt\/16.11.2146","article-title":"Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension","volume":"16","author":"Quaschning","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","article-title":"Addition of spironolactone to ACE inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial NO synthase expression","volume":"39","author":"Bauersachs","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2006.00996.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.00996.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.00996.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T20:18:13Z","timestamp":1707077893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.00996.x"}},"subtitle":["ALDOSTERONE AND HEART FAILURE"],"short-title":[],"issued":{"date-parts":[[2008,10,9]]},"references-count":59,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.00996.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10,9]]}}}